SPSB2 inhibits hepatitis C virus replication by targeting NS5A for ubiquitination and degradation

PLoS One. 2019 Jul 25;14(7):e0219989. doi: 10.1371/journal.pone.0219989. eCollection 2019.

Abstract

Hepatitis C virus (HCV) replication involves many viral and host factors. Host factor SPRY domain- and SOCS box-containing protein 2(SPSB2) belongs to SPSB family, and it recruits target proteins by the SPRY domain and forms E3 ubiquitin ligase complexes by the SOCS box. As an adaptor protein, it can regulate the host's response to infection, but little is known about whether SPSB2 plays a role in HCV replication. In the present study, we found that HCV infection significantly upregulated the mRNA and protein levels of SPSB2 in HCVcc-infected cells. Exogenous expression of SPSB2 in hepatoma cells decreased HCV RNA and protein levels which depended on the SOCS box, while knockdown of endogenous SPSB2 increased HCV RNA and protein levels. Additionally, we demonstrated that SPSB2 interacted with HCV structural protein E1 and nonstructural protein protein 5A (NS5A) via the C-terminal portion of the SPSB2 SPRY domain. Furthermore, SPSB2 induced NS5A ubiquitination and mediated NS5A degradation. Collectively, this study discovered host factor SPSB2 significantly inhibits HCV replication by interacting and degrading NS5A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Cell Line, Tumor
  • HEK293 Cells
  • Hepacivirus / physiology*
  • Hepatitis C / genetics
  • Hepatitis C / metabolism*
  • Humans
  • Protein Binding
  • Proteolysis
  • Suppressor of Cytokine Signaling Proteins / chemistry
  • Suppressor of Cytokine Signaling Proteins / genetics
  • Suppressor of Cytokine Signaling Proteins / metabolism*
  • Ubiquitination
  • Up-Regulation
  • Viral Nonstructural Proteins / chemistry*
  • Viral Nonstructural Proteins / metabolism*
  • Virus Replication

Substances

  • SPSB2 protein, human
  • Suppressor of Cytokine Signaling Proteins
  • Viral Nonstructural Proteins
  • NS-5 protein, hepatitis C virus

Grants and funding

This work was supported by the National Natural Sciences Foundation of China (No. 31370185), the National Basic Research Program of China (No. 2011CB504800), the National Infrastructure of Natural Resources for Science and Technology Program (No.2011-572) to Prof. C Zheng, and the National Science and Technology Infrastructure Grant NSTI-CR15 and NSTI-CR16 and the Fundamental Research Funds for the Central Universities (2042018kf0241) to Dr. Chao Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.